Cargando…
NF-κB Inhibition Suppresses Experimental Melanoma Lung Metastasis
BACKGROUND: Although novel therapeutic regimens for melanoma continue to emerge, the best current clinical response rate is still less than 60%. Moreover, antimelanoma treatments contribute to toxicities in other vital organs. In this study, we elucidate the therapeutic advantages of siRNA targeting...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497821/ https://www.ncbi.nlm.nih.gov/pubmed/32954352 http://dx.doi.org/10.26502/jcsct.5079070 |